Improving the use of research evidence in guideline development: Introduction

Health Research Policy and Systems

Volumn 4, Issue , 2006, Pages

  Oxman, Andrew D ^a   Fretheim, Atle ^a   Schünemann, Holger J ^b   Haines, Andy ^c   Langer, Ana ^c   Pang, Tikki ^c   Panisset, Ulysses ^c   Whitworth, Judith ^c  

^a NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c WHO

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; MEDICAL RESEARCH; RESEARCH ETHICS; REVIEW; WORLD HEALTH ORGANIZATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL RESEARCH; DECISION MAKING; HEALTH CARE COST; HEALTH CARE DISTRIBUTION; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SURVEY; MEDLINE; METHODOLOGY; PRACTICE GUIDELINE; RESEARCH PRIORITY; RESOURCE ALLOCATION; SOCIOECONOMICS;

EID: 33845270331     PISSN: 14784505     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-4-12     Document Type: Review

References (31)

1. Oxman AD, Guyatt GH: The science of reviewing research. Annals of the New York Academy of Science 1993, 703:125-34.
2. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992, 268:240-248.
3. Silagy CA, Stead LF, Lancaster T: Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ 2001, 323:833-36.
4. Vigna-Taglianti F, Vineis P, Liberati A, Faggiano F: Quality of systematic reviews used in guidelines for oncology practice. Annals of Oncology 2006, 17:691-701.
5. Bradbury J: Storm over WHO-ISH hypertension guidelines. Lancet 1999, 353:563.
6. Horton R: WHO: the casualties and compromises of renewal. Lancet 2002, 359:1605-11.
7. Laing R, Waning B, Gray A, Ford N, t Hoen E: 25 years of the WHO essential medicines lists: progress and challenges. Lancet 2003, 36:1723-9.
8. McCarthy M: Critics slam draft WHO report on homoeopathy. Lancet 2005, 366:705.
9. Oxman AD, Lavis JN, Fretheim A: The use of evidence in WHO recommendations. Lancet in press.
10. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J: Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999, 281:1900-5.
11. Grilli R, Magrini N, Penna A, Mura G, Liberati A: Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000, 355:103-6.
12. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H: Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998, 317:858-61.
13. Lavis JN, Posada FB, Haines A, Osei E: Use of research to inform policymaking. Lancet 2004, 364:1615-21.
14. Lavis JN, Davies H, Oxman AD, Denis JL, Golden-Biddle K, Ferlie E: Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy 2005, 10(Suppl 1):35-48.
15. Sheldon TA: Making evidence synthesis more useful for management and policy-making. J Health Serv Res Policy 2005, 10(suppl 1):1-5.
16. Schünemann HJ, Fretheim A, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 1. Guidelines for guidelines. Health Res Policy Syst 2006.
17. Oxman AD, Schünemann HJ, Fretheim A: Improving the Use of Research Evidence in Guideline Development: 2. Priority setting. Health Res Policy Syst 2006.
18. Fretheim A, Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 3. Group composition. Health Res Policy Syst 2006.
19. Boyd E, Bero L: Improving the Use of Research Evidence in Guideline Development. 4. Managing conflicts of interest. Health Res Policy Syst 2006.
20. Fretheim A, Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 5. Group processes. Health Res Policy Syst 2006.
21. Schünemann HJ, Oxman AD, Fretheim A: Improving the Use of Research Evidence in Guideline Development: 6. Determining which outcomes are important. Health Res Policy Syst 2006.
22. Oxman AD, Fretheim A, Schünemann HJ: Improving the Use of Research Evidence in Guideline Development: 7. Deciding what evidence to include. Health Res Policy Syst 2006.
23. Oxman AD, Schünemann HJ, Fretheim A: Improving the Use of Research Evidence in Guideline Development: 8. Synthesis and presentation of evidence. Health Res Policy Syst 2006.
24. Schünemann HJ, Fretheim A, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 9. Grading evidence and recommendations. Health Res Policy Syst 2006.
25. Schünemann HJ, Fretheim A, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 10. Integrating values and consumer involvement. Health Res Policy Syst 2006.
26. Edejer TTT: Improving the Use of Research Evidence in Guideline Development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications. Health Res Policy Syst 2006.
27. Oxman AD, Schünemann HJ, Fretheim A: Improving the Use of Research Evidence in Guideline Development: 12. Incorporating considerations of equity. Health Res Policy Syst 2006.
28. Schünemann HJ, Fretheim A, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 13. Adaptation, applicability and transferability. Health Res Policy Syst 2006.
29. Oxman AD, Fretheim A, Schünemann HJ: Improving the Use of Research Evidence in Guideline Development: 14. Reporting guidelines. Health Res Policy Syst 2006.
30. Fretheim A. Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 15. Disseminating and implementing guidelines. Health Res Policy Syst 2006.
31. Oxman AD, Fretheim A, Schünemann HJ: Improving the Use of Research Evidence in Guideline Development: 16. Evaluation. Health Res Policy Syst 2006.